Evidence map›Paper›PMID 33406961›Full record

ArticleOphthalmic genetics2021

Clinical trial design for neuroprotection in

Benjamin Otte, Chris Andrews, Gabrielle Lacy, Kari Branham, David C Musch, Kanishka T Jayasundera

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Ophthalmic genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Benjamin OtteDepartment of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, MI, USA.
Chris AndrewsDepartment of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, MI, USA.
Gabrielle LacyDepartment of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, MI, USA.ORCID 0000-0002-3746-9326
Kari BranhamDepartment of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, MI, USA.
David C MuschDepartment of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, MI, USA.ORCID 0000-0002-4164-3841
Kanishka T JayasunderaDepartment of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, MI, USA.ORCID 0000-0003-4895-4818
University of Michigan · US

Funding

Targeted functional testing for retinal diseases based on patient reported outcomesK23EY026985 · NEI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI JAYASUNDERA, KANISHKA THIRAN · 2016 to 2020
$1.2M
NEI NIH HHS K23 EY026985
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Genes, DominantNeuroprotectionVisual FieldsAdolescentAdultAgedAged, 80 and overChildChild, PreschoolClinical Trials as TopicFemaleHumansMaleMiddle AgedResearch DesignRetinitis Pigmentosarho GTP-Binding ProteinsAutosomal Dominant Retinitis PigmentosaEllipsoid zoneGoldmann Visual Fieldmixed effectsneuroprotectionOptical Coherence Tomographyretinal degenerationrhodopsin

Identifiers

PMID33406961
PMCPMC7987885
OpenAlexW3118741556

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.